Document is current
Any future updates will be listed below
-
Authors
Ueda-Consolvo, Tomoko
Ishida, Masaaki
Nakamura, Tomoko
Yanagisawa, Shuichiro
Tsuboi, Kotaro
Wakabayashi, Taku https://orcid.org/0000-0003-2640-6079
Hayashi, Atsushi
Sharma, Ashish https://orcid.org/0000-0002-8550-9791
,
Kuppermann, Baruch D.
Loewenstein, Anat
Bandello, Francesco
Regillo, Carl D.
Nicholson, Luke
Vazquez-Alfageme, Clara
Kumar, Nilesh
Parachuri, Nikulaa
Sheth, Jay
Ayachit, Seemantini
Mishra, Chitaranjan
Chakraborty, Debdulal
Banker, Alay
Rezaei, Kourous A.
Khanani, Arshad M.
Kaiser, Peter K.
Tadayoni, Ramin
Holz, Frank G.
Sivaprasad, Sobha
Sarraf, David
Querques, Giuseppe
Özdek, Şengül
Laurent, Kodjikian
Bilgic, Alper
Lanzetta, Paolo
Baumal, Caroline
Holekemp, Nancy
Sakamoto, Taiji
Tufail, Adnan
Yannuzzi, Nicolas
Corradetti, Giulia
Hilely, Assaf
Boyer, David
Rachitskaya, Aleksandra
Peto, Tunde
Wintergerst, Maximilian W. M.
Sarao, Valentina
Parolini, Barbara
Mruthyunjaya, Prithvi
Nguyen, Quan Dong
DO, Diana V.
Keane, Pearse A.
Hassan, Tarek
Sridhar, Jayanth
Eichenbaum, David
Grewal, Dilraj S.
March, Francesc
Splitzer, Martin
Zinkernage, Martin S.
- License Information
-
More Information
Article History
Received: 23 May 2024
Revised: 10 June 2024
Accepted: 3 July 2024
First Online: 23 July 2024
Competing interests
: Ashish Sharma: CONSULTANT: for Novartis, Allergan, Bayer and Intas. Tomoko Ueda-Consolvo Masaaki Ishida, Tomoko Nakamura, Shuichiro Yanagisawa, and Taku Wakabayashi: None.
